Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1600911 | 1.00 | CETP (0.42) | CETPTACR1 | |
| SCHEMBL1601549 | 1.00 | CETP (0.42) | CETPTACR1 | |
| SCHEMBL1600786 | 1.00 | CETP (0.42) | CETPTACR1 | |
| SCHEMBL1601267 | 0.99 | CETP (0.42) | CETPTACR1 | |
| SCHEMBL1600245 | 0.99 | CETP (0.42) | CETPTACR1 | |
| SCHEMBL12707795 | 0.99 | CETP (0.42) | CETPTACR1 | |
| SCHEMBL1600687 | 0.97 | CETP (0.42) | CETPTACR1 | |
| SCHEMBL1601335 | 0.89 | CETP (0.37) | CETP | |
| SCHEMBL1599672 | 0.88 | CETP (0.41) | CETP | |
| SCHEMBL1600305 | 0.88 | CETP (0.42) | CETP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8703204-B2 | Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer | BEND RESEARCH, INC. (US) | 2014-04-22 | — | — | US | claimed |
| US-7919506-B2 | Dibenzyl amine compounds and derivatives | PFIZER INC. (US) | 2011-04-05 | — | — | US | claimed |
| US-20100129447-A1 | NANOPARTICLES COMPRISING A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR AND ANON-IONIZABLE POLYMER | BEND RESEARCH, INC. | 2010-05-27 | — | — | US | claimed |
| US-20100062073-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING NANOPARTICLES COMPRISING ENTERIC POLYMERS CASEIN | BEND RESEARCH, INC. | 2010-03-11 | — | — | US | claimed |
| WO-2008135855-A2 | NANOPARTICLES COMPRISING A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR AND A NONIONIZABLE POLYMER | PFIZER PRODUCTS INC. (US) | 2008-11-13 | — | — | WO | claimed |
| WO-2008065502-A1 | PHARMACEUTICAL COMPOSITIONS BASED ON A) NANOPARTICLES COMPRISING ENTERIC POLYMERS AND B) CASEIN | PFIZER PRODUCTS INC. (US) | 2008-06-05 | — | — | WO | claimed |
| US-20070213371-A1 | Dibenzyl Amine Compounds and Derivatives | PFIZER INC | 2007-09-13 | — | — | US | claimed |
| US-9724362-B2 | Pharmaceutical compositions comprising nanoparticles and a resuspending material | BEND RESEARCH, INC. (US) | 2017-08-08 | — | — | US | disclosed |
| US-9545384-B2 | Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate | BEND RESEARCH, INC. (US) | 2017-01-17 | — | — | US | disclosed |
| EP-2231169-B1 | PHARMACEUTICAL COMPOSITIONS COMPRISING NANOPARTICLES AND A RESUSPENDING MATERIAL | BEND RES INC (US) | 2016-05-04 | — | — | EP | disclosed |
| EP-2162120-B1 | NANOPARTICLES COMPRISING A NON-IONIZABLE CELLULOSIC POLYMER AND AN AMPHIPHILIC NON-IONIZABLE BLOCK COPOLYMER | BEND RES INC (US) | 2016-05-04 | — | — | EP | disclosed |
| US-9233078-B2 | Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer | BEND RESEARCH, INC. (US) | 2016-01-12 | — | — | US | disclosed |
| US-8974827-B2 | Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer | BEND RESEARCH, INC. (US) | 2015-03-10 | — | — | US | disclosed |
| WO-2008135828-A2 | NANOPARTICLES COMPRISING A DRUG, ETHYLCELLULOSE, AND A BILE SALT | PFIZER PRODUCTS INC. (US) | 2008-11-13 | — | — | WO | disclosed |
| WO-2008065502-A1 | PHARMACEUTICAL COMPOSITIONS BASED ON A) NANOPARTICLES COMPRISING ENTERIC POLYMERS AND B) CASEIN | PFIZER PRODUCTS INC. (US) | 2008-06-05 | — | — | WO | disclosed |
| WO-2007105050-A1 | DIBENZYL AMINE COMPOUNDS AND DERIVATIVES | PFIZER PRODUCTS INC. (US) | 2007-09-20 | — | — | WO | disclosed |
| WO-2007105050-A1 | DIBENZYL AMINE COMPOUNDS AND DERIVATIVES | PFIZER PRODUCTS INC. (US) | 2007-09-20 | — | — | WO | disclosed |
| US-20070213371-A1 | Dibenzyl Amine Compounds and Derivatives | PFIZER INC | 2007-09-13 | — | — | US | disclosed |
| US-20070213371-A1 | Dibenzyl Amine Compounds and Derivatives | PFIZER INC | 2007-09-13 | — | — | US | disclosed |
| US-20070213371-A1 | Dibenzyl Amine Compounds and Derivatives | PFIZER INC | 2007-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100129447-A1 | NANOPARTICLES COMPRISING A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR AND ANON-IONIZABLE POLYMER | CETP, CHLSN, PCTP | CETP 1/4885TACR1 3164/4885 |
| US-20100062073-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING NANOPARTICLES COMPRISING ENTERIC POLYMERS CASEIN | CSNK1G3, CSNK2A3, CSNK1A1 | CETP 54/4885TACR1 3473/4885 |
| US-20070213371-A1 | Dibenzyl Amine Compounds and Derivatives | APOB, LDLR, CETP | CETP 3/4885TACR1 2334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.